Sandra Adele

Sandra is a scientist and epidemiologist who recently completed her DPhil in Clinical Medicine at the Centre for Tropical Medicine and Global Health. Her research focused on the immunological responses to COVID-19 vaccines, using data from healthcare workers and vulnerable populations. 

Sandra has worked on global health initiatives focused on strengthening health systems through responsive surveillance systems, pandemic preparedness, and universal health coverage. She has also contributed to projects addressing malaria vaccine rollout, antimicrobial resistance, and reproductive health in fragile and conflict-affected regions. Currently, she works at the World Health Organization Headquarters on strengthening infectious disease surveillance. 

SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses.

Dejnirattisai, Wanwisa, et al, (2022), Cell 2021.

______________________________________

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. 

Payne, Rebecca P. et al, (2021), Cell 184.23 5699-5714.

_________________________________________

Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern.  

Skelly D, et al, Nature Communications 12, 5061 (2021)                                                                             _________________________________________

Adele S. et al, (2020) Integrating Neglected Tropical Diseases into Universal Health Coverage. n.d.2020

_________________________________________

Institute for Health Metrics and Evalution (IHME). S. Adele COVID-19 and Malaria.2020           

Adele Sandra. One size does not fit all. Personalised Medicine. Oxford Scientist